Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anika Therapeutics (ANIK)
NASDAQ:ANIK
Holding ANIK?
Track your performance easily
Earnings Data
Report Date
Feb 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.23Last Year’s EPS
$0.05Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 31, 2024
|% Change Since: -33.91%
|Next Earnings Date:Feb 20, 2025
Earnings Call Sentiment|Neutral
The call highlighted strategic shifts focusing on HA-based products and international growth. However, significant challenges included the divestiture of underperforming assets and declining U.S. revenue. Despite these setbacks, growth in international markets and regulatory progress for key products provide a positive outlook.Company Guidance
In the third-quarter earnings call for Anika on October 31, 2024, the company provided a comprehensive update on its strategic direction and financial guidance. Anika announced a significant strategic pivot, focusing on its HA-based products, including Integrity, Hyalofast, and Cingal, which are projected to drive commercial channel growth. The restructuring involves selling Arthrosurface and planning to divest Parcus Medical, reducing global headcount from approximately 325 to 225, and reclassifying revenue into commercial and OEM channels for better shareholder visibility. For 2024, Anika anticipates 14% to 19% growth in the commercial channel, while the OEM channel is expected to decline by 8% to 10%. Looking ahead, Anika targets double-digit revenue growth in the commercial channel, predicting a 12% to 18% increase in 2025 and 20% to 30% annually in 2026 and 2027. Adjusted EBITDA for 2024 is guided between $16 million and $18 million, with projected low double-digit EBITDA margins for 2025. The call underscored Anika's commitment to aligning its resources and investments towards its high-growth potential HA-driven products and markets.Strategic Shift and Focus
Anika is focusing on differentiated HA-based products targeting a $4 billion market for OA pain management and Regenerative Solutions.
Integrity Product Growth
Integrity surgeries increased by over 40% sequentially in Q3 2024, with more than 500 surgeries since its late 2023 launch.
International OA Pain Sales Growth
International OA pain sales grew by 7% in Q3 2024 and 14% year-to-date, driven by geographic expansion.
Hyalofast Progress
The first module of the PMA for Hyalofast was filed with the FDA, targeting a U.S. launch by 2026 in a $1 billion market.
Cingal Regulatory Progress
Acquired the Aristospan NDA, clearing a major FDA hurdle, and began additional nonclinical testing for Cingal.
Projected Commercial Channel Growth
Commercial channel revenue is expected to grow 14% to 19% for 2024, with double-digit growth projected through 2027.
---
ANIK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ANIK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 31, 2024 | $24.68 | $17.11 | -30.67% |
| Aug 08, 2024 | $25.68 | $25.68 | 0.00% |
| May 08, 2024 | $28.47 | $25.26 | -11.28% |
| Mar 13, 2024 | $25.40 | $24.54 | -3.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Anika Therapeutics (ANIK) report earnings?
Anika Therapeutics (ANIK) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
What is Anika Therapeutics (ANIK) earnings time?
Anika Therapeutics (ANIK) earnings time is at Feb 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ANIK EPS forecast?
ANIK EPS forecast for the fiscal quarter 2024 (Q4) is -$0.23.
---